| Withdrawn | An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pedi Pain, Postoperative, Pediatrics | Phase 3 | 2008-10-01 |
| Completed | Bioequivalence Between Integrated E-TRANS (Fentanyl) System and Separated (Two-Part) E-TRANS (Fentanyl) System Pain, Postoperative | Phase 1 | 2008-03-01 |
| Terminated | A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg) Pain | — | 2007-12-01 |
| Completed | A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy Narcolepsy | Phase 2 | 2007-01-01 |
| Completed | Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-44 Chronic Small Plaque Psoriasis | Phase 2 | 2006-09-01 |
| Completed | A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Sch Pain, Postoperative | Phase 3 | 2004-04-01 |
| Completed | A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Tot Pain, Postoperative, Analgesia | Phase 3 | 2004-03-01 |
| Completed | A Study to Evaluate the Effectiveness and Safety of Slow Release Hydromorphone HCL for Treatment of Patients W Osteoarthritis, Hip, Osteoarthritis, Knee | Phase 3 | 2003-11-01 |
| Completed | A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation. Ejaculation | Phase 3 | 2003-06-01 |
| Completed | Pharmacokinetics of Naltrexone Following Intravenous and Oral Routes of Administration in Healthy Volunteers Biological Availability | Phase 1 | 2003-05-01 |
| Completed | Pharmacokinetics of Fentanyl Following Intravenous and Oral Routes of Administration in Healthy Volunteers Biological Availability | Phase 1 | 2003-04-01 |
| Completed | A Study to Evaluate the Safety of D-TRANS Fentanyl With Naltrexone in Adult Patients With Chronic Pain and Who Chronic Pain | Phase 2 | 2003-01-01 |
| Completed | An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidat Attention Deficit Hyperactivity Disorder | Phase 3 | 1998-11-01 |
| Completed | A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Plac Attention Deficit Hyperactivity Disorder | Phase 3 | 1998-03-01 |
| Completed | A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary Inc Urinary Incontinence | Phase 3 | 1997-03-01 |
| Completed | A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutyn Urge Incontinence | Phase 3 | 1996-07-01 |
| Completed | Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Inconti Urinary Incontinence | Phase 3 | 1995-12-01 |
| Completed | Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Pati Pain, Cancer | Phase 3 | 1987-10-01 |
| Completed | Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cance Pain, Cancer | Phase 3 | 1986-05-01 |
| Completed | Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-release) Tablets and Immediate-R Pain | Phase 3 | — |
| Completed | An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release) Osteoarthritis, Knee, Osteoarthritis, Hip | Phase 3 | — |
| Completed | Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Re Low Back Pain | Phase 3 | — |
| Completed | A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Low Back Pain | Phase 2 | — |
| Completed | A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients. Pain, Analgesics, Opioid | Phase 3 | — |
| Completed | A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HC Attention Deficit Hyperactivity Disorder | Phase 3 | — |
| Completed | A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets Pain, Analgesics, Opioid | Phase 1 | — |
| Completed | An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg Analgesia | Phase 1 | — |
| Completed | An Open-Label Evaluation of the Independent Effects of Coadministration of a High-Fat Meal and Naltrexone Bloc Analgesia | Phase 1 | — |
| Completed | Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release) Pain, Analgesics, Opioid | Phase 3 | — |
| Completed | Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Trea Urinary Incontinence | Phase 3 | — |
| Completed | A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients Wi Analgesics, Opioid, Pain | Phase 3 | — |
| Completed | A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone i Pain, Postoperative, Orthopedic Procedures, Analgesia | Phase 2 | — |
| Completed | A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation Ejaculation | Phase 3 | — |
| Completed | A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Pain, Analgesics, Opioid | Phase 3 | — |
| Completed | Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivit Attention Deficit Hyperactivity Disorder | Phase 3 | — |
| Completed | Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain Analgesics, Opioid, Pain | Phase 3 | — |
| Completed | An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation Ejaculation, Erectile Dysfunction, Sexual Dysfunction | Phase 3 | — |